Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
1.330
+0.020 (1.53%)
Aug 15, 2025, 10:57 AM - Market open
Citius Pharmaceuticals Employees
Citius Pharmaceuticals had 23 employees as of September 30, 2024. The number of employees increased by 1 or 4.55% compared to the previous year.
Employees
23
Change (1Y)
1
Growth (1Y)
4.55%
Revenue / Employee
n/a
Profits / Employee
-$1,782,197
Market Cap
14.86M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 23 | 1 | 4.55% |
Sep 30, 2023 | 22 | 1 | 4.76% |
Sep 30, 2022 | 21 | 6 | 40.00% |
Sep 30, 2021 | 15 | 5 | 50.00% |
Sep 30, 2020 | 10 | 1 | 11.11% |
Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CTXR News
- 2 days ago - Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 4 weeks ago - Citius Oncology Announces Closing of $9.0 Million Public Offering - PRNewsWire
- 4 weeks ago - Citius Oncology Announces Pricing of $9.0 Million Public Offering - PRNewsWire
- 4 weeks ago - Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora - PRNewsWire
- 5 weeks ago - Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - PRNewsWire
- 2 months ago - Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025 - PRNewsWire
- 2 months ago - Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - PRNewsWire
- 2 months ago - Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - PRNewsWire